| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Jan―16 |
State of type 2 diabetic Iraqi patients after hospitalization for COVID-19 |
Hiba S Ahmed, Haylim N Abud, Hind S Ahmed |
| 2 |
[GO] |
2024―Sep―13 |
The potential role of dyslipidemia in COVID-19 severity among Iraqi patients |
Hind S. Ahmed, Hiba S. Ahmed |
| 3 |
[GO] |
2024―Sep―03 |
Relation of ICAM-1 and VCAM-1 markers in COVID-19 patients in Kirkuk province |
Zubaida Najat Mustafa Albarzanji, Nuha Mumin Wahid, Najlaa Bakir Shaker, Zaid Mohammed Al-Bayati |
| 4 |
[GO] |
2024―Jul―19 |
Evaluation of SARS-Cov-2 neutralizing antibody among Sinopharm Vero Cell (BBIBP-CorV) vaccinated medical students |
Sony Khadka, Sanjib Mani Regmi, Nuwadatta Subedi, Arjun Poudel, Dhaka Ram Bhandari, Mitesh Karn, Shanti Pradhan, Prabin Shrestha |
| 5 |
[GO] |
2024―Mai―17 |
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination |
Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, Fouad Seghrouchni, Youssef Bakri |
| 6 |
[GO] |
2024―Mai―17 |
Development and characterization of three novel mouse monoclonal antibodies targeting spike protein S1 subunit of Middle East Respiratory Syndrome Corona Virus |
Aymn T. Abbas, Sherif A. El-Kafrawy, Ashraf A. Tabll, Anwar M. Hashem, Tagreed L. Al Subhi, Mohammed Alsaadi, Esam I. Azhar |
| 7 |
[GO] |
2024―Apr―19 |
The role of vitamin D against COVID-19 infection, progression and severity |
Hiba Sh. Ahmed, Hind Sh. Ahmed, Haylim N. Abud |
| 8 |
[GO] |
2024―Mrz―22 |
Expression level of non-coding (MiR-155) gene as biomarker for severity of Coronaviruses infection among vaccinated and non-vaccinated Iraqi patients |
Halah Kadhim, Abdulameer Ghareeb, Mohammed Alhilal |
| 9 |
[GO] |
2024―Feb―09 |
Effect of physical exercise on inactivated COVID-19 vaccine antibody response in the elderly |
Ömer Şevgin, Songül Özer |
| 10 |
[GO] |
2023―Dez―19 |
Time-series bioinformatics analysis of SARS-CoV-infected cells to identify the biological processes associated with severe acute respiratory syndrome |
Razieh Fatehi, Farinaz Khosravian, Mansoor Salehi, Mohammad Kazemi |
| 11 |
[GO] |
2023―Jul―18 |
Effect of IL-6 and CRP titer with antibody level on severity of COVID-19 infection |
Adeq K. Hachim, Aesha Saber Ali, Khalid B. Arif |
| 12 |
[GO] |
2023―Jul―11 |
Evaluation of IL-6 and IL-17A gene polymorphisms in Iraqi patients infected with COVID-19 and type 2 diabetes mellitus |
Qusay Abdulwahab Khalaf, Khetam Habeeb Rasool, Eman Natiq Naji |
| 13 |
[GO] |
2023―Jul―11 |
SARS-CoV-2 strain-specific anti-spike IgG ELISA utilizing spike protein produced by silkworms |
Takeyuki Goto, Tomoki Sasaki, Yong Chong, Masahiro Taniguchi, Jae Man Lee, Akitsu Masuda, Takeru Ebihara, Kenichiro Shiraishi, Naoki Tani, Akiko Yonekawa, Kei Gondo, Hiroyuki Kuwano, Nobuyuki Shimono, Hideyuki Ikematsu, Koichi Akashi, Takahiro Kusakabe |
| 14 |
[GO] |
2023―Jun―13 |
Immunoglobulin G follow-up and immune response longevity analysis in SARS-CoV-2 convalescent patients and vaccinated individuals: A longitudinal analysis |
Fadia Mothafar Maki, Anima Namma AL-Thwani, Kareem Shahal Jiad, Karar Nadhum Jawad Musafer |
| 15 |
[GO] |
2023―Mai―23 |
Postural orthostatic tachycardia syndrome-like symptoms following COVID-19 vaccination: An overview of clinical literature |
Phu TV, Thu Thao Tran, Huynh Trung Hao, Nguyen Thi Hien Hau, Nityanand Jain, Aigars Reinis |
| 16 |
[GO] |
2023―Jan―03 |
The impact of HIV on the risk of COVID-19 death among hospitalized patients |
Mehdi Azizmohammad Looha, Nazanin Taraghikhah, Maedeh Amini, Pegah Salimi Pormehr, Negin Talaei, Mahmood Khodadoost, Saeid Gholamzadeh, Reza Vafaee, Gohar Mohammadi |
| 17 |
[GO] |
2022―Jun―29 |
Comparison of some hematological parameters between male and female patients infected with COVID-19 |
Hayder H. Abed, Ahmed Ghdhban Al-Ziaydi, Ihab Abbas Taher, Ahmed K. Al Dulaimi |
| 18 |
[GO] |
2022―Apr―12 |
Assessment of specific human antibodies against recombinant SARS-CoV-2 receptor binding domain by rapid in-house ELISA |
Nahla A. Hussein, Esraa A.A. Ali, Amr E. El-Hakim, Ashraf A. Tabll, Asmaa El-Shershaby, Azza Salamony, Mohamed N.F. Shaheen, Ibrahim Ali, Mahmoud Elshall, Yasser E. Shahein |
| 19 |
[GO] |
2021―Nov―30 |
COVID-19 pandemic: Insights into genetic susceptibility to SARS-CoV-2 and host genes implications on virus spread, disease severity and outcomes |
Saba Dastar, Jalal Gharesouran, Deniz Mortazavi, Hassan Hosseinzadeh, Seyed Jalal Kian, Mohammad Taheri, Soudeh Ghafouri-Fard, Elena Jamali, Maryam Rezazadeh |
| 20 |
[GO] |
2021―Jun―15 |
Detection of SARS-CoV-2 antibodies in pediatric patients: An Iranian referral hospital-based study |
Setareh Mamishi, Golnaz Ghazizadeh Esslami, Mohsen Mohammadi, Mohammad Reza Abdolsalehi, Reihaneh Hosseinpour Sadeghi, Shima Mahmoudi, Babak Pourakbari |
| 21 |
[GO] |
2021―Mai―11 |
A review on monoclonal antibodies in COVID-19: Role in immunotherapy, vaccine development and viral detection |
Ashraf A. Tabll, Yasser E. Shahein, Mohamed M. Omran, Mostafa M. Elnakib, Ameera A. Ragheb, Khaled E. Amer |
| 22 |
[GO] |
2021―Mrz―09 |
Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens |
Mitra Rezaei, Mohammadhadi Sadeghi, Alireza Korourian, Payam Tabarsi, Mihan Porabdollah, Elham Askari, Esmaeil Mortaz, Shima Mahmoudi, Majid Marjani |
| 23 |
[GO] |
2020―Sep―22 |
Clinical and demographic characteristics of patients with COVID-19 infection: Statistics from a single hospital in Iran |
Majid Samsami, Elham Mehravaran, Payam Tabarsi, Abdolreza Javadi, Shahram Arsang-Jang, Alireza Komaki, Mohammad Taheri, Soudeh Ghafouri-Fard |
| 24 |
[GO] |
2020―Sep―22 |
COVID-19: Significance of antibodies |
Sara Assadiasl, Yousef Fatahi, Mahdi Zavvar, Mohammad Hossein Nicknam |
| 25 |
[GO] |
2020―Aug―25 |
Global public health significances, healthcare perceptions of communities, treatments, prevention and control methods of COVID-19 |
Addis Adera Gebru, Tadesse Birhanu, Eshetu Wendimu, Agumas Fentahun Ayalew, Selamawit Mulat, Hussen Zakir Abasimel, Ali Kazemi, Bosenu Abera Tadesse, Beniam Adera Gebru, Berhanu Senbeta Deriba, Nigus Shimelis Zeleke, Abebe Gule Girma, Bulgantsetseg Munkhbat, Qamar Kassim Yusuf, Amana Ogeto Luke, Dejene Hailu |
| 26 |
[GO] |
2020―Aug―25 |
The Level of risk, Effects response to potential health Emergencies, Prevention and control method of COVID-19: A systematic review |
Addis Adera Gebru, Tadesse Birhanu, Eshetu Wendimu, Agumas Fentahun Ayalew, Selamawit Mulat, Hussen Zakir Abasimel, Ali Kazemi, Bosenu Abera Tadesse, Beniam Adera Gebru, Berhanu Senbeta Deriba, Nigus Shimelis Zeleke, Abebe Gule Girma, Bulgantsetseg Munkhbat, Qamar Kassim Yusuf, Amana Ogeto Luke, Dejene Hailu |
| 27 |
[GO] |
2020―Aug―11 |
Global burden of COVID-19: Situational analyis and review |
Addis Adera Gebru, Tadesse Birhanu, Eshetu Wendimu, Agumas Fentahun Ayalew, Selamawit Mulat, Hussen Zakir Abasimel, Ali Kazemi, Bosenu Abera Tadesse, Beniam Adera Gebru, Berhanu Senbeta Deriba, Nigus Shimelis Zeleke, Abebe Gule Girma, Bulgantsetseg Munkhbat, Qamar Kassim Yusuf, Amana Ogeto Luke, Dejene Hailu |
| 28 |
[GO] |
2020―Mai―12 |
Zero tolerance for complacency by government of West African countries in the face of the COVID-19 pandemic |
O. Erhabor, T. Erhabor, T.C. Adias, G.C. Okara, M. Retsky |
|
